Health Tech

ABC Impact is a Singapore-based private equity impact fund focused on scaling companies that deliver measurable social and environmental outcomes across Asia. Backed by Temasek Holdings, the firm invests in growth-stage businesses across sectors like financial inclusion, healthcare, education, and climate, with a disciplined approach to both impact measurement and financial returns.

Accelerating Asia Ventures is the leading early-stage venture capital accelerator in Southeast Asia and South Asia, focusing specifically on pre-Series A startups. They operate as both an accelerator and VC fund, targeting high-potential founders with real traction and grit who may not have traditional backgrounds but demonstrate strong business fundamentals. Their mission centers on investing in the region's best pre-Series A startups by providing capital, credibility, and hands-on partnership to help founders reach the next level. Licensed by the Monetary Authority of Singapore, they fill a crucial gap in the funding ecosystem by focusing on startups that are 6-18 months away from institutional funding - companies with robust products at early stages of customer traction that are often overlooked by other investors. Accelerating Asia serves as a catalyst for positive change by backing undiscovered entrepreneurs and providing investor partners with systematic access to innovation in Asia's most dynamic markets. They focus not just on financial returns but on profitability, growth, and impact, operating with the guiding belief that entrepreneurs are one of humanity's greatest catalysts for positive change.

Acumen is a venture philanthropy organization that invests in visionary entrepreneurs building transformational companies from seed to scale. They focus on funding bold entrepreneurs who are creating inclusive solutions across sectors like sustainable agriculture, quality education, renewable energy, healthy communities, dignified jobs, and gender equality. Their mission is to break the cycle of poverty through patient capital investments in high-innovation, high-impact enterprises. They operate by deploying philanthropic capital to shape markets and support entrepreneurs who are addressing the world's toughest poverty-related challenges, investing where traditional funders won't. Acumen Ventures has established itself as a significant force in the impact investing ecosystem since 2001, with an A to Z directory of portfolio companies spanning over two decades. They matter because they've reinvented the rules of return, prioritizing impact alongside financial sustainability and helping to demonstrate that venture philanthropy can drive meaningful systemic change in underserved communities globally.

Adenia Partners is a private markets investment firm focused on growth opportunities across Africa. Founded in 2002, the firm invests in high-potential companies that drive economic development while delivering strong financial returns. With offices across key African markets, Adenia Partners works closely with management teams to scale businesses, improve operational performance, and expand regional footprint. The firm integrates ESG and impact considerations into its investment strategy, with a focus on building resilient businesses that contribute to long-term economic growth on the continent.

AlphaLab is a nationally recognized startup accelerator based in Pittsburgh, supporting early-stage companies across software, hardware, life sciences, and robotics. Founded in 2008 and powered by Innovation Works, AlphaLab provides founders with capital, mentorship, and a structured program to accelerate growth. The platform operates multiple specialized tracks, including AlphaLab (software), AlphaLab Gear (hardware), AlphaLab Health (life sciences), and Robotics Factory, offering tailored support depending on the company’s sector. AlphaLab has played a key role in building Pittsburgh into a leading innovation hub, helping startups move from idea to scalable venture.

The American Heart Association Social Impact Funds are investment vehicles managed by American Heart Association, focused on advancing health equity and improving cardiovascular outcomes. The funds invest in companies addressing social determinants of health, access to care, and innovations that reduce disparities in underserved communities. By combining mission-driven capital with strategic partnerships, the platform supports startups and growth-stage companies working across healthcare, digital health, and community-based solutions that improve long-term health outcomes.

Angelini Ventures is the venture capital arm of Angelini Industries, investing in innovative startups across biotech and digital health. The firm focuses on advancing healthcare through breakthrough therapies, medical technologies, and data-driven solutions. With a global investment strategy, Angelini Ventures backs early and growth-stage companies working to improve patient outcomes and transform how diseases are treated and managed. The firm combines capital with deep industry expertise and strategic support from its parent organization.

Ashoka is one of the world’s leading organizations supporting social entrepreneurs. Founded in 1980, Ashoka pioneered the concept of social entrepreneurship and has built a global network of changemakers working to solve some of the world’s most pressing challenges. Through its flagship Ashoka Fellows program, the organization identifies and supports high-impact entrepreneurs with funding, mentorship, and a powerful global network. Ashoka’s broader mission is to create a world where everyone is a changemaker, embedding social innovation across education, business, and civil society.

Bain Capital Double Impact is the impact investing strategy of Bain Capital, focused on building market-leading companies that deliver both strong financial returns and measurable social and environmental impact. The platform leverages Bain Capital’s global reach and sector expertise to scale businesses across healthcare, sustainability, and inclusive growth. The firm partners with management teams to drive operational improvements, expand market reach, and embed impact into core business strategy. Its approach combines rigorous private equity discipline with a commitment to long-term, responsible value creation.

Better Ventures is an early-stage impact venture capital firm investing in founders building solutions to some of the world’s most pressing challenges. The firm backs companies across climate, health, circular economy, PropTech, and sustainable consumer sectors, with a focus on scalable technologies that deliver measurable impact. Operating with an “impact + return” philosophy, Better Ventures supports entrepreneurs not just with capital, but with access to a curated network of operators, angels, and advisors. The firm positions founders as the drivers of change, helping them scale companies that generate both financial returns and meaningful environmental and social outcomes.

Hopelab is a researcher, investor, and convener that focuses on equity-centered solutions for the mental health and well-being of Black, Brown, and Queer young people. They operate through multiple modalities including research, investment in innovators, and funding youth-centered solutions to advance mental health outcomes for underserved communities. Their mission is to advance the mental health and well-being of young people through uncovering knowledge and evidence, investing in innovators, and funding youth-centered solutions. Hopelab operates as an intergenerational collaborator, believing that equitable outcomes require partnership and shifting power dynamics to center young people's perspectives and lived expertise. Hopelab serves as a critical player in the mental health ecosystem by centering equity in all facets of their work and recognizing that systems of oppression like racism, homophobia, transphobia, and wealth inequities are interconnected. They amplify young leaders' voices and create opportunities to challenge existing narratives, spark dialogue, and inspire collective growth, making them essential advocates for dismantling barriers that prevent young people from living joyful and purposeful lives.

LeapFrog Investments is a private equity firm that focuses on scaling purpose-driven businesses across Asia and Africa to achieve sustainable growth, profitability, and measurable social impact. The firm invests in companies operating primarily in three key sectors: financial services, healthcare, and climate solutions, targeting businesses that serve emerging consumers and low-income populations. LeapFrog operates on a "profit with purpose" model, partnering with business leaders to drive integrated returns that combine financial performance with social impact. Their approach is grounded in a clear theory of change aimed at empowering low-income consumers to become agents of their own transformation, providing them with tools and services to make entrepreneurial leaps out of poverty. The firm provides not just capital but also resources and expertise to help portfolio companies reach emerging consumers at scale with relevant, affordable, and essential services. LeapFrog has established itself as a significant player in the impact investing ecosystem, demonstrating that commercial returns and social impact can be successfully integrated. Their rigorous approach to impact measurement, aligned with UN Sustainable Development Goals, sets industry standards for transparency and accountability in impact investing. The firm's scale of operation, reaching 559 million people through their portfolio companies and supporting 33 million jobs, positions them as a major force in driving inclusive economic growth in emerging markets.

Masawa Fund is a European venture capital fund that invests in seed-stage startups focused on mental health and wellness solutions. They target companies working on mental illness cures, mental wellness improvement, and addressing social determinants of mental health including sleep, nutrition, and loneliness. The fund operates in a $400 billion market, recognizing that 1 in 5 people will develop a mental health condition and that mental ill-health costs the EU €630 billion annually. Masawa operates through their "Nurture Capital" approach, which puts humans at the center of their investment strategy and focuses on organizational health and founder wellbeing to minimize risk. Their mission is to advance human flourishing by weaving people, purpose, and prosperity together, creating a compassionate world where people can thrive and reach their potential. The fund was sparked by their founder's personal experience with mental illness and their vision of making wellness accessible to all. Masawa matters in the ecosystem because they are addressing a critical gap where 65% of startups fail from people problems, and founders face 2-3 times higher rates of depression and substance abuse than the general population. They are working to humanize finance and evolve venture capital by supporting purpose-driven founders who are solving real human needs. Their approach recognizes that inner transformation enables outer change, positioning mental health as a catalyst for broader social and environmental solutions.

SOSV is a global venture capital firm and accelerator founded in 1995, operating one of the most active deep tech and life sciences investment programs in the world. The firm runs multiple accelerator programs, including HAX for hardware and robotics, IndieBio for life sciences and biotech, and Orbit for climate and sustainability — providing intensive company-building support alongside early-stage capital. With over $1.5 billion in AUM and a portfolio exceeding 1,000 companies across more than 70 countries, SOSV occupies a distinctive position in the venture landscape: a programmatic investor that takes companies from idea stage through to growth and beyond. The firm's accelerator model means it is often the first institutional check into a company, with follow-on capability through later rounds. SOSV has a strong impact orientation across its portfolio, with climate, food systems, health, and sustainability representing a significant share of its investments. Its programs in particular have become known as launchpads for companies working on hard scientific and engineering problems that require more than capital to succeed.

T1D Fund is the world's first scaled venture fund dedicated exclusively to type 1 diabetes, operating as an impact investment fund that supports promising companies through equity investments and expertise. They focus specifically on accelerating treatments, prevention, and cures for the approximately 9 million people living with T1D globally. The fund operates as a powerful platform for collaboration, using catalytic capital and expertise to de-risk investments and create a flywheel effect that attracts other investors to the T1D space. As a wholly owned, not-for-profit independently run subsidiary of Breakthrough T1D, they leverage their intellectual capital and expert network to offer comprehensive support to portfolio companies, steering them through regulatory, clinical, and commercial milestones. With over $200 million in assets under management and 25+ active portfolio companies, T1D Fund creates significant impact in the diabetes ecosystem by reinvesting 100% of returns to propel continuous progress. Their unique position as subject matter experts combined with access to Breakthrough T1D's extensive network of research, clinical, and medical expertise enables them to transform the landscape of T1D investment and accelerate the development of life-changing therapies.